Investments in Zoonotic Disease Treatment: Major Companies Focus on Advanced Diagnostics and Therapeutic Innovations Trend: A Crucial Influence on the Zoonotic Disease Treatment Market's Transformation in 2025

What Is the Expected Size and Growth Rate of the Zoonotic Disease Treatment Market?
The market for treating zoonotic diseases has seen substantial expansion in the recent past. The market, valued at $39.71 billion in 2024, is projected to increase to $42.64 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. The substantial growth during the historical period can be associated with various factors such as the appearance of significant zoonotic disease outbreaks, urban development, habitat intrusion, adoption of a unified health approach, enhancements in surveillance and reporting, globalization, increased travel, along with heightened public knowledge and education.

In the coming years, the zoonotic disease treatment market is projected to experience substantial expansion. Its value is anticipated to reach $55.92 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. The surge over the forecast period can be traced back to factors such as climate change and environmental conditions, government and international funding, advancements in the medical technology field, regulatory encouragement and streamlined approval processes, and joint research and development efforts. The forecasted period is expected to see notable trends including the creation of broad-spectrum antivirals, fortification of the global health infrastructure, progressive strides in diagnostic technology, the expansion in vaccine development mechanisms, and increased emphasis on preventive strategies.

What Factors Are Fueling Growth in the Zoonotic Disease Treatment Market?
The surge in the demand for animal proteins is predicted to accelerate the expansion of the zoonotic disease treatment market. Animal proteins, derived from meat, dairy, eggs, and fish, are full of essential amino acids vital for human health. Factors such as a growing global population, rising income levels, urbanization, and an increased awareness of the nutritional values of animal-based food have escalated the need for animal proteins. Zoonotic disease treatments provide invaluable perspectives in controlling and understanding diseases arising from animal proteins, along with enabling the development of impactful therapies and undertaking preventive tactics to curb public health threats. For example, a report issued by the Organization for Economic Co-operation and Development, alongside the Food and Agriculture Organization in July 2023 stated that the consumption of meat worldwide is set to grow at an annual pace of 0.1% as indicated by a US-based agricultural commodity market. This uptick is mostly influenced by the mounting demand in middle and lower-income nations, expecting poultry to make up nearly half of all meat production growth by 2032. Thus, this surge in animal protein demand fuels the advancement of the zoonotic disease treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Leading Companies Are Shaping the Growth of the Zoonotic Disease Treatment Market?
Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

What Are the Major Trends Shaping the Zoonotic Disease Treatment Market?
Prominent enterprises in the zoonotic disease treatment market are prioritizing investments in their respective treatment methods to augment diagnostic abilities and refine treatment procedures. The focus is on creating superior diagnostic technologies, such as PCR kits, for hastening the detection of zoonotic pathogens and establishing targeted therapeutic strategies. In October 2023, for instance, BioPerfectus, a Chinese biotechnology firm specializing in diagnostic services, introduced thirteen additional members to its Zoonotic Infectious Diseases Total PCR Solution. This initiative is expected to strengthen its diagnostic potential for zoonotic diseases, which represent over 60% of recognized infectious diseases and 75% of emerging infections. The move is strategically aimed at enhancing preparedness and responsiveness in health security, especially in light of the spread of infectious diseases to newer regions due to climate change. By launching these new products, the company expects to facilitate faster diagnoses and more effective management of zoonotic infections, underlining the need for preemptive public health actions.

What Are the Key Segments of the Zoonotic Disease Treatment Market?
The zoonotic disease treatment market covered in this report is segmented -

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:
1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment
3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment
6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Dominates the Zoonotic Disease Treatment Market?
North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Zoonotic Disease Treatment Global Market Report?

- Market Size Analysis: Analyze the Zoonotic Disease Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Zoonotic Disease Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Zoonotic Disease Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Zoonotic Disease Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.